Portal Vein Thrombosis (DBCOND0042200)

Identifiers

Synonyms
Thrombosis Portal Vein / Portal vein thrombosis / Portal (vein) obstruction / Portal vein thrombosis (disorder) / Pylethrombosis / Portal vein occlusion / Portal vein obstruction / Portal vein obstruction (disorder)

Associated Data

Indicated Drugs and Targets
Not Available
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT03422419
TIPS or Anticoagulation in Portal Vein Thrombosistreatment3withdrawn
NCT02526303
Anticoagulation for Non-occlusive Portal Vein Thrombosis in Patients With Liver CirrhosistreatmentNot Availablewithdrawn
NCT03193502
Efficacy and Safety of Rivaroxaban in the Management of Acute Non-neoplastic PVT Compensated Cirrhosistreatment3unknown_status
NCT04976543
Safety of Anticoagulant Therapy After Endoscopic Treatmenttreatment4completed
NCT06122753
Preemptive TIPS for Variceal Bleeding in Cirrhotic Patients With Occlusive Portal Vein ThrombosisNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT01470547
Portal Vein Thrombosis Relevance on Liver Cirrhosis: Italian Venous Thrombotic Events RegistryNo drug interventionsNot AvailableNot Availablecompleted
NCT06117488
Risk Factors and Management Outcome of Chronic Portal Vein Thrombosis in ChildrenNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT06150807
Portal Vein Thrombosis in Neonate With Umbilical CatheterNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT01690715
Prognostic Value Related to the Presence of Thrombosis or Portal Vein Invasion in Patients With Hepatocellular Carcinoma Submitted to SurgeryNo drug interventionsNot AvailableNot Availableterminated
NCT01326949
Transjugular Intrahepatic Portosystemic Shunt (TIPS) for Prevention of Variceal Rebleeding in Cirrhotic Patients With Portal Vein ThrombosisNo drug interventionstreatmentNot Availablecompleted
NCT02585713
Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolismsupportive_care3completed
NCT05872841
H101 Combined With TACE for Primary Hepatocellular Carcinoma With Portal Vein ThrombosisNo drug interventionstreatment2not_yet_recruiting
NCT03031717
Clinical Course of Cirrhotic Patients With Portal Vein Thrombosis Treated With TIPSNo drug interventionsNot AvailableNot Availableunknown_status
NCT05166239
HAIC Combine With Lenvatinib and PD-1 Inhibitors for Advanced HCC With PVTTtreatment2recruiting
NCT03541057
Vienna Vascular Liver Disease StudyNo drug interventionsNot AvailableNot Availablerecruiting
NCT05123326
Global Coagulation Assessment in Portal Vein Thrombosis and Budd-Chiari SyndromeNo drug interventionsNot AvailableNot Availablerecruiting
NCT02853526
TIPS for Variceal Rebleeding in Cirrhotic Patients With Occlusive Portal Vein Thrombosis and CTPVtreatment3unknown_status
NCT01556282
TheraSpheres Treatment for Unresectable Hepatocarcinoma and Portal Vein ThrombosisNo drug interventionstreatmentNot Availablecompleted
NCT04181931
Neo-TACE-HAIC for PVTT-HCCNo drug interventionstreatmentNot Availablerecruiting
NCT06319131
Nadroparin Versus TIPS in Cirrhotic Patients With Refractory Asymptomatic PVTtreatmentNot Availablenot_yet_recruiting
NCT00769873
Anticoagulation Post Laparoscopic Splenectomyprevention2terminated
NCT05541562
A Practical Nomogram Based on Systemic Inflammatory Markers for Predicting Portal Vein Thrombosis in Patients With Liver CirrhosisNo drug interventionsNot AvailableNot Availablecompleted
NCT06513780
A Study of the Correlation Between Portal Vein Thrombosis and Prognosis of Liver TransplantationNo drug interventionsNot AvailableNot Availablerecruiting
NCT04055389
Preventing de Novo Portal Vein Thrombosis With Antithrombin-III in Patients With Cirrhosisprevention1withdrawn
NCT05132192
Living Donor Liver Transplantation to Patients With Portal Vein ThrombosisNo drug interventionsNot AvailableNot Availablecompleted
NCT03201367
Efficacy and Safety of Rivaroxaban in Acute Non-neoplastic Portal Vein Thrombosis in HCVtreatmentNot Availablecompleted
NCT05339581
IMRT Plus PD-1 Blockade and Lenvatinib for HCC With PVTT (Vp3) Before Liver TransplantationtreatmentNot Availableunknown_status
NCT02630095
The Effect of Anticoagulation in Cirrhotic Patients With Portal Vein Thrombosis:A Multicenter RCTtreatment4unknown_status
NCT04387695
SBRT+TACE+Sorafenib Vs Sorafenib in the Treatment of uHCC With PVTTtreatment3recruiting
NCT02485184
TIPS vs Endoscopic Therapy for Variceal Rebleeding in Cirrhotic Patients With Portal Vein ThrombosistreatmentNot Availablerecruiting
NCT02627053
Treatment of Splanchnic Vein Thrombosis With Rivaroxaban. A Pilot, Prospective Cohort Studytreatment3unknown_status
NCT01631877
Efficacy and Safety of Acenocoumarol for Treatment of Nontumor Portal Vein Thrombosis in Cirrhosis of LivertreatmentNot Availablewithdrawn
NCT03631147
The Effect of Rifaximin on Portal Vein ThrombosistreatmentNot Availableunknown_status
NCT06005883
Surgical Outcome of HCC With Portal Vein Tumor Thrombosis on the Basis of Risk ScoringNo drug interventionsNot AvailableNot Availablecompleted
NCT03009461
Sorafenib Plus Hepatic Arterial Infusion Versus Sorafenib for HCC With Major Portal Vein Tumor Thrombosistreatment2completed
NCT05625893
Proton Beam Radiotherapy Followed by Tecentriq and Avastin for Primary Liver Cancer With Vp2-4 Portal Vein InvasionNo drug interventionstreatment2recruiting
NCT03902678
Role of EUS Guided FNA of Portal Vein Thrombus in the Diagnosis and Staging of Hepatocellular CarcinomaNo drug interventionsdiagnosticNot Availableunknown_status
NCT05782556
Freiburg TIPS RegistryNo drug interventionsNot AvailableNot Availablerecruiting
NCT01095185
Efficacy of Statin Association With Standard Treatment in Prevention of Recurrent Hemorrhage in Patient With Cirrhosis and Variceal Bleedingtreatment3completed
NCT02733770
Chances in Portal System Flow After Two Bariatric ProceduresNo drug interventionsdiagnosticNot Availableunknown_status
NCT03477149
EASYX-1 : A Multicenter Study on Safety and Efficacy of Easyx Liquid Embolization Agent Used in Five Separate IndicationsNo drug interventionstreatmentNot Availablecompleted
NCT05360641
Risk Factors for Recurrence of Thrombosis or Thrombotic Extension, in the Event of Acute Non-cirrhotic Portal Vein Thrombosis Secondary to a Local Cause.No drug interventionsNot AvailableNot Availablecompleted
NCT02069457
Prevalence and Predictive Factors of Portal Vein Thrombosis in Patients With CirrhosisNo drug interventionsNot AvailableNot Availablecompleted
NCT02398357
The Effect of Anticoagulation After Endoscopic Therapy in Cirrhotic Patients With Portal Vein Thrombosistreatment4unknown_status
NCT02250391
Placebo-controlled Study of NPB-06 in Patients With Portal Vein ThrombosisNo drug interventionstreatment3completed
NCT04173429
Efficacy and Safety of Anticoagulant Therapy in Portal Vein Thrombosistreatment4completed
NCT05012501
Analysis of Neutrophil Extracellular Traps in Hypercoagulability and Portal Vein Thrombosis in Liver Cirrhosis PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT04433481
Efficacy and Safety of Dabigatran in Patients With Cirrhosis and Portal Vein ThrombosistreatmentNot Availableunknown_status